Xtant Medical Holdings (XTNT) Equity Average (2011 - 2025)
Xtant Medical Holdings (XTNT) reported Equity Average of $50.7 million for Q4 2025, up 14.26% year-over-year from $44.3 million in Q4 2024, and up 2.48% on a QoQ basis from $49.4 million in Q3 2025.
Xtant Medical Holdings (XTNT) has 15 years of Equity Average data on file, last reported at $50.7 million in Q4 2025.
- Quarterly Equity Average rose 14.26% year-over-year to $50.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $50.7 million (up 14.26% YoY) and the FY2025 annual result came in at $47.0 million, changed 0.42% from the prior year.
- Equity Average climbed to $50.7 million in Q4 2025 per XTNT's latest filing, from $49.4 million in the prior quarter.
- Across five years, Equity Average topped out at $53.0 million in Q4 2023 and bottomed at $23.9 million in Q1 2021.
- The 5-year median for Equity Average is $38.2 million (2021), against an average of $39.1 million.
- The widest annual swing landed in 2021, when Equity Average jumped 5823.51%; it then decreased 16.36% in 2024.
- Tracing XTNT's Equity Average over 5 years: stood at $31.8 million in 2021, then increased by 5.39% to $33.5 million in 2022, then jumped by 58.39% to $53.0 million in 2023, then declined by 16.36% to $44.3 million in 2024, then rose by 14.26% to $50.7 million in 2025.
- Per Business Quant, the three latest XTNT Equity Average figures stand at $50.7 million (Q4 2025), $49.4 million (Q3 2025), and $46.2 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.70 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.03 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.85 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.53 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.18 Bn |
| 10 | Xtant Medical Holdings | 64.46 Mn | 47.14 Mn | 17.75 Mn | 50.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 50.67 Mn |
| Sep 30, 2025 | 49.44 Mn |
| Jun 30, 2025 | 46.19 Mn |
| Mar 31, 2025 | 43.42 Mn |
| Dec 31, 2024 | 44.34 Mn |
| Sep 30, 2024 | 45.37 Mn |
| Jun 30, 2024 | 46.34 Mn |
| Mar 31, 2024 | 49.51 Mn |
| Dec 31, 2023 | 53.02 Mn |
| Sep 30, 2023 | 42.82 Mn |
| Jun 30, 2023 | 31.83 Mn |
| Mar 31, 2023 | 33.44 Mn |
| Dec 31, 2022 | 33.47 Mn |
| Sep 30, 2022 | 30.46 Mn |
| Jun 30, 2022 | 28.71 Mn |
| Mar 31, 2022 | 30.08 Mn |
| Dec 31, 2021 | 31.76 Mn |
| Sep 30, 2021 | 33.26 Mn |
| Jun 30, 2021 | 33.63 Mn |
| Mar 31, 2021 | 23.94 Mn |
| Dec 31, 2020 | 31.25 Mn |
| Sep 30, 2020 | 561,500.00 |
| Jun 30, 2020 | -46.67 Mn |
| Mar 31, 2020 | -45.34 Mn |
| Dec 31, 2019 | -43.53 Mn |
| Sep 30, 2019 | -41.97 Mn |
| Jun 30, 2019 | -40.13 Mn |
| Mar 31, 2019 | -41.47 Mn |
| Dec 31, 2018 | -15.56 Mn |
| Sep 30, 2018 | 11.63 Mn |
| Jun 30, 2018 | 13.11 Mn |
| Mar 31, 2018 | -21.55 Mn |
| Dec 31, 2017 | -44.46 Mn |
| Sep 30, 2017 | -26.07 Mn |
| Jun 30, 2017 | -17.10 Mn |
| Mar 31, 2017 | -9.68 Mn |
| Dec 31, 2016 | -6.09 Mn |
| Sep 30, 2016 | -2.80 Mn |
| Jun 30, 2016 | 1.43 Mn |
| Mar 31, 2016 | 6.12 Mn |
| Dec 31, 2015 | 3.02 Mn |
| Sep 30, 2015 | -7.34 Mn |
| Jun 30, 2015 | -11.16 Mn |
| Mar 31, 2015 | -9.12 Mn |
| Jun 30, 2014 | -7.26 Mn |
| Mar 31, 2014 | -5.20 Mn |
| Dec 31, 2013 | -2.24 Mn |
| Sep 30, 2013 | 1.40 Mn |
| Jun 30, 2013 | 3.05 Mn |
| Mar 31, 2013 | 3.44 Mn |
| Dec 31, 2012 | 6.41 Mn |
| Sep 30, 2012 | 9.37 Mn |
| Jun 30, 2012 | 9.56 Mn |
| Mar 31, 2012 | 7.24 Mn |
| Dec 31, 2011 | 7.09 Mn |
| Sep 30, 2011 | 8.83 Mn |